NASDAQ: PMCB - PharmaCyte Biotech, Inc.

छह महीने के लिए लाभप्रदता: -30.89%
भाग प्रतिफल: 0.00%
सेक्टर: Healthcare

पदोन्नति कार्यक्रम PharmaCyte Biotech, Inc.

उन्नत शेड्यूल सरल ग्राफ
Financial Markets by TradingView

कंपनी के बारे में PharmaCyte Biotech, Inc.

PharmaCyte Biotech, Inc., a biotechnology company, focuses on developing and commercializing cellular therapies for cancer, diabetes, and malignant ascites in the United States. Its cellular therapies are developed based on Cell-in-a-Box, a proprietary cellulose-based live cell encapsulation technology used as a platform to treat various types of cancer, including advanced and inoperable pancreatic cancer, as well as diabetes.

अधिक जानकारी
The company is developing therapies for pancreatic and other solid cancerous tumors; a therapy for Type 1 diabetes and insulin-dependent Type 2 diabetes, which include encapsulated genetically modified insulin-producing cells; and therapies for cancer based on the constituents of the cannabis plant. It has a research agreement with the University of Technology, Sydney to create a version of melligen cells to treat diabetes. The company was formerly known as Nuvilex, Inc. and changed its name to PharmaCyte Biotech, Inc. in January 2015. PharmaCyte Biotech, Inc. was incorporated in 1996 and is headquartered in Las Vegas, Nevada.
तुलना सूची में जोड़ें
घड़ी सूची में जोड़ें
पोर्टफोलियो में जोड़ें
मूल्य सूचना जोड़ें

IPO date 2010-09-17
ISIN US71715X2036
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://pharmacyte.com
Цена ао 1.49
प्रति दिन मूल्य परिवर्तन: -4.35% (1.38)
प्रति सप्ताह मूल्य परिवर्तन: -16.46% (1.58)
प्रति माह मूल्य परिवर्तन: -23.26% (1.72)
3 महीने में कीमत में बदलाव: -15.92% (1.57)
छह महीने में कीमत में बदलाव: -30.89% (1.91)
प्रति वर्ष मूल्य परिवर्तन: -44.3% (2.37)
3 वर्षों में मूल्य परिवर्तन: -45.68% (2.43)
5 वर्षों में मूल्य परिवर्तन: +2 488.24% (0.051)
वर्ष की शुरुआत से मूल्य परिवर्तन: -15.92% (1.57)
सभी पैरामीटर

बहुत मूल्यवान समझना

नाम अर्थ श्रेणी
P/S 0 0
P/BV 0.514 10
P/E 60.86 1
EV/EBITDA -89.49 0
कुल: 3.63

क्षमता

नाम अर्थ श्रेणी
ROA, % 0.5012 1
ROE, % 0.5949 1
कुल: 0.3333

लाभांश

नाम अर्थ श्रेणी
Div yield, % 0 0
DSI 0 0
कुल: 0.0212

कर्तव्य

नाम अर्थ श्रेणी
Debt/EBITDA 0 10
कुल: 10

विकास का आवेग

नाम अर्थ श्रेणी
लाभप्रदता Revenue, % -98.14 0
लाभप्रदता Ebitda, % -108.78 0
लाभप्रदता EPS, % -1344.13 0
कुल: 0
अधिक जानकारी

संस्थानों आयतन शेयर करना, %
K2 Principal Fund, L.P. 304613 0.01
Geode Capital Management, LLC 215637 0.01
Vanguard Group Inc 171335 0.01
Equitec Proprietary Markets LLC 82727 0
Sabby Management, LLC 82373 0
Renaissance Technologies, LLC 38100 0
Dimensional Fund Advisors LP 29307 0
Blackrock Inc. 28769 0
Citadel Advisors Llc 28618 0
Schonfeld Strategic Advisors LLC 23200 0

ETF शेयर करना, % वर्ष के लिए लाभप्रदता, % लाभांश, %
Dimensional U.S. Targeted Value ETF 0.00013 26.01 1.93487
Dimensional U.S. Core Equity 2 ETF 0.00006 30.76 1.47098



पर्यवेक्षक नौकरी का शीर्षक भुगतान जन्म का साल
Mr. Joshua N. Silverman Interim CEO, Interim President & Interim Chairman 197.92k 1970 (55 साल)
Mr. Carlos A. Trujillo CPA, CPA Chief Financial Officer 380k 1958 (67 साल)
Dr. Jose L. Iglesias M.D. Consulting Chief Medical Officer N/A 1957 (68 साल)
Dr. Hans-Peter Hammes Member of Medical & Scientific Advisory Board and Consultant N/A

पता: United States, Las Vegas. NV, 3960 Howard Hughes Parkway - Google मानचित्र में खोलें, यांडेक्स मानचित्र खोलें
वेबसाइट: https://pharmacyte.com